van Meenen, Laura C. C.
van Stigt, Maritta N.
Marquering, Henk A.
Majoie, Charles B. L. M.
Roos, Yvo B. W. E. M.
Koelman, Johannes H. T. M.
Potters, Wouter V.
Coutinho, Jonathan M. http://orcid.org/0000-0002-8284-982X
Funding for this research was provided by:
Hartstichting
Health~Holland
Medtronic (Unrestricted grant)
Article History
Received: 9 March 2021
Revised: 27 August 2021
Accepted: 27 August 2021
First Online: 2 September 2021
Declarations
:
: Charles Majoie reports grants from CVON/Dutch Heart Foundation, European Commission, TWIN Foundation, Stryker, and Dutch Health Evaluation Program, all outside the submitted work (paid to institution), and is shareholder of Nico.lab, a company that focuses on the use of artificial intelligence for medical image analysis. Yvo Roos is a minor shareholder of Nico.lab. Henk Marquering is co-founder and shareholder of Nico.lab. Jonathan Coutinho received related research support from the Dutch Heart Foundation and Medtronic and unrelated research support from Bayer and Boehringer. All fees were paid to his employer. The other authors report no conflicts.
: Permission to carry out ELECTRA-STROKE was granted by the medical ethics committee of the Amsterdam UMC, location AMC. All enrolled patients or their legal representatives provided written informed consent. A deferred consent procedure was approved by the ethical review board, meaning that informed consent was asked after acquisition of the EEG, as soon as logistically feasible (preferably within 72 h after arrival at the hospital or at discharge).